Health Sciences Group to Air Sequesterol(TM) Infomercial in Test Markets.

LOS ANGELES -- Health Sciences Group, Inc. (OTCBB:HESG), provider of innovative health and wellness products, announced that it will begin airing a 30-minute television infomercial for its Sequesterol(TM) nutritional supplement. The advertisement will air initially in test markets around the nation; it is expected to move subsequently to broader release.

"The launch of this infomercial is a long time coming," said Health Sciences Group's new Chief Executive Officer Stuart Gold, "but we felt it best to go the extra distance in the production process. We retained the services of Take 2 Direct, a recognized leader in direct response television (DRTV) marketing. Their expertise in infomercial production and strategic marketing management is expected to ensure that Sequesterol has the best possible marketing platform. We are excited about this campaign and the prospect for future healthy-living products which we plan to introduce."

Sequesterol Advanced Cardio Formula includes vital nutrients which support cardiovascular health and help maintain a free-flowing circulatory system(a). This proprietary formulation is based on a unique combination of clinically-studied ingredients known to support healthy cholesterol levels, reduce the formation of plaque and protect against heart attack(a). According to the American Heart Association, heart disease affects 1-in-3 adults and claims a life every 33 seconds. More information is available at www.Sequesterol.com.

"We are proud of the Sequesterol infomercial," commented Adam MacDonald, President and Chief Executive Officer of Take 2 Direct. "It is a high quality presentation which uses graphics, animation and testimonials to inform and educate viewers on the nation's #1 killer -- heart disease. We believe this commercial delivers a compelling message for Sequesterol as a natural approach to address heart disease."

Take 2 Direct has produced successful DRTV campaigns for products such as White Brilliance(R), Collagen(R), Tribal Fitness(R), Hooked On Phonics(R) and Palm Pilates(R).

(a) Statements relating to the health effects of Sequesterol have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

About Health Sciences Group

Health Sciences Group is dedicated to developing and acquiring unique and innovative products that support and enhance a "healthstyle" with a focus on nutrition, wellness and functional well-being. For more information, visit www.HSHealthStyle.com and www.Sequesterol.com.

About Take 2 Direct

Take 2 Direct is one of the top infomercial production companies in the industry. As a "one-stop-shop" for direct response television commercials, Take 2 provides everything from scripting, talent screening and production to media purchasing, test airing analysis and back-end process support including merchant processing, fulfillment and campaign management. Take 2 has produced award winning infomercials for leading industry companies including Smart Inventions, University Medical Products, Aloette Cosmetics, White Brilliance(R), Collagen(R), Tribal Fitness(R), Hooked On Phonics(R) and Palm Pilates(R). For more information, visit www.take2direct.com.

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including without limitation, the independent authority of the special committee to act on the matters discussed, the successful negotiation of the potential acquisition and disposal of transactions described above, successful implementation of the company's business strategy and competition, any of which may cause actual results to differ materially from those described in the statements. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent Form 10-QSB and Form 10-KSB filings with the Securities and Exchange Commission.